Fig. 2From: The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocolTimeline of interventions and assessments for the WIRE trial. *Optional, **Only in patients with cM1 disease. US: ultrasoundBack to article page